Scottsdale, AZ, USA – Aurea Vita Advisors, a leading consulting firm specializing in human blood-plasma collection solutions, announced the addition of Chris Barber to its executive team as Managing Director, International Business effective MAY 01, 2024, further solidifying the firm’s commitment to excellence, innovation, and international expansion in the rapidly evolving plasma-derived therapies industry.
Charles Auger, the CEO and Principal of Aurea Vita Advisors, expressed his enthusiasm about the milestone, highlighting his longstanding relationship with Barber spanning over 25 years. “I have known Chris for over two decades, and am confident that our synergy will create an unparalleled force in the plasma collection consulting space at the global level. Together, we bring a unique blend of skills that will greatly benefit our clients and the patients they ultimately serve.”
In this strategic addition, Chris Barber will focus exclusively on Aurea Vita Advisors’ international business activities and projects, while Charles Auger will continue leading efforts servicing US clients, as well as heading global regulatory matters. This division of responsibilities leverages Chris Barber’s extensive experience as a plasma collection integrator and operator, specializing in expanding and scaling operations, and incorporating new technologies. Meanwhile, Charles Auger excels in navigating governmental regulatory challenges and designing plasma collection organizations to ensure product quality and donor safety.
Aurea Vita Advisors is poised to offer comprehensive solutions for all components of a high-performing plasma collection enterprise worldwide, thanks to the combined expertise of Charles, Chris, and the teams they can deploy. “AVA is positioning with the global industry trend of nations seeking self-sufficiency to protect their citizens, as the demand for plasma-derived therapies is expected to grow at a compelling 8-12% CAGR through 2032,” remarked Barber.
“We believe Chris joining AVA will significantly enhance our ability to provide guidance and management solutions for plasma collection networks worldwide,” stated Auger. “Our shared vision for safe and reliable source plasma and hyperimmune supplies for patients around the world will undoubtedly benefit clients seeking to navigate the complexities of the evolving plasma industry.”
For more information about Aurea Vita Advisors and their comprehensive plasma collection enterprise solutions, please visit www.AureaVitaAdvisors.com.
About Aurea Vita Advisors:
Aurea Vita Advisors is a leading international consulting firm specializing in plasma collection enterprise optimization. With a team of seasoned industry experts, AVA provides comprehensive solutions for organizations seeking to excel in the dynamic and rapidly growing field of plasma-derived therapies.
Media ContactCompany Name: Aurea Vita AdvisorsContact Person: Media RelationsEmail: Send EmailCountry: United StatesWebsite: www.AureaVitaAdvisors.com
